Lysophosphatidylcholine Potentiates Antibacterial Activity of Polymyxin B
Keyword(s):
ABSTRACT Polymyxin B, used to treat infections caused by antibiotic-resistant Gram-negative bacteria, produces nephrotoxicity at its current dosage. We show that a combination of nonbactericidal concentration of this drug and lysophosphatidylcholine (LPC) potently inhibits growth of Salmonella and at least two other Gram-negative bacteria in vitro. This combination makes bacterial membrane porous and causes degradation of DnaK, the regulator of protein folding. Polymyxin B-LPC combination may be an effective and safer regimen against drug-resistant bacteria.
2011 ◽
Vol 56
(3)
◽
pp. 1458-1465
◽
2011 ◽
Vol 56
(3)
◽
pp. 1452-1457
◽
2020 ◽
2017 ◽
Vol 05
(01)
◽
pp. 26-48
◽
Keyword(s):
2019 ◽
Vol 20
(7)
◽
pp. 1699
◽
2018 ◽
Vol 45
(3)
◽
pp. 555-565
◽